These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16505760)

  • 1. Fatty infiltration of the liver. Detection and grading using dual T1 gradient echo sequences on clinical MR system.
    Pilleul F; Chave G; Dumortier J; Scoazec JY; Valette PJ
    Gastroenterol Clin Biol; 2005 Nov; 29(11):1143-7. PubMed ID: 16505760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver steatosis quantification using magnetic resonance imaging: a prospective comparative study with liver biopsy.
    Mennesson N; Dumortier J; Hervieu V; Milot L; Guillaud O; Scoazec JY; Pilleul F
    J Comput Assist Tomogr; 2009; 33(5):672-7. PubMed ID: 19820490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver steatosis: investigation of opposed-phase T1-weighted liver MR signal intensity loss and visceral fat measurement as biomarkers.
    Bahl M; Qayyum A; Westphalen AC; Noworolski SM; Chu PW; Ferrell L; Tien PC; Bass NM; Merriman RB
    Radiology; 2008 Oct; 249(1):160-6. PubMed ID: 18796674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy.
    Idilman IS; Aniktar H; Idilman R; Kabacam G; Savas B; Elhan A; Celik A; Bahar K; Karcaaltincaba M
    Radiology; 2013 Jun; 267(3):767-75. PubMed ID: 23382293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty infiltration of the liver: quantification with phase-contrast MR imaging at 1.5 T vs biopsy.
    Levenson H; Greensite F; Hoefs J; Friloux L; Applegate G; Silva E; Kanel G; Buxton R
    AJR Am J Roentgenol; 1991 Feb; 156(2):307-12. PubMed ID: 1898804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver fat: effect of hepatic iron deposition on evaluation with opposed-phase MR imaging.
    Westphalen AC; Qayyum A; Yeh BM; Merriman RB; Lee JA; Lamba A; Lu Y; Coakley FV
    Radiology; 2007 Feb; 242(2):450-5. PubMed ID: 17255416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy.
    van Werven JR; Marsman HA; Nederveen AJ; Smits NJ; ten Kate FJ; van Gulik TM; Stoker J
    Radiology; 2010 Jul; 256(1):159-68. PubMed ID: 20574093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques--initial experience.
    Qayyum A; Goh JS; Kakar S; Yeh BM; Merriman RB; Coakley FV
    Radiology; 2005 Nov; 237(2):507-11. PubMed ID: 16244259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic macrosteatosis: predicting appropriateness of liver donation by using MR imaging--correlation with histopathologic findings.
    Kim SH; Lee JM; Han JK; Lee JY; Lee KH; Han CJ; Jo JY; Yi NJ; Suh KS; Shin KS; Jo SY; Choi BI
    Radiology; 2006 Jul; 240(1):116-29. PubMed ID: 16684918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperechoic liver nodules: characterization with proton fat-water chemical shift MR imaging.
    Martín J; Puig J; Falcó J; Donoso L; Rué M; Sentís M; Darnell A; Musulén E
    Radiology; 1998 May; 207(2):325-30. PubMed ID: 9577476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques.
    Schwenzer NF; Machann J; Martirosian P; Stefan N; Schraml C; Fritsche A; Claussen CD; Schick F
    Invest Radiol; 2008 May; 43(5):330-7. PubMed ID: 18424954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive quantification of hepatic steatosis in living, related liver donors using dual-echo Dixon imaging and single-voxel proton spectroscopy.
    Krishan S; Jain D; Bathina Y; Kale A; Saraf N; Saigal S; Choudhary N; Baijal SS; Soin A
    Clin Radiol; 2016 Jan; 71(1):58-63. PubMed ID: 26555703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic steatosis in living liver donor candidates: preoperative assessment by using breath-hold triple-echo MR imaging and 1H MR spectroscopy.
    Hwang I; Lee JM; Lee KB; Yoon JH; Kiefer B; Han JK; Choi BI
    Radiology; 2014 Jun; 271(3):730-8. PubMed ID: 24533869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic MR imaging for in vivo differentiation of steatosis, iron deposition and combined storage disorder: single-ratio in/opposed phase analysis vs. dual-ratio Dixon discrimination.
    Bashir MR; Merkle EM; Smith AD; Boll DT
    Eur J Radiol; 2012 Feb; 81(2):e101-9. PubMed ID: 21330083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T.
    Yokoo T; Bydder M; Hamilton G; Middleton MS; Gamst AC; Wolfson T; Hassanein T; Patton HM; Lavine JE; Schwimmer JB; Sirlin CB
    Radiology; 2009 Apr; 251(1):67-76. PubMed ID: 19221054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment of intrahepatic lipids using fat-selective imaging with spectral-spatial excitation and in-/opposed-phase gradient echo imaging techniques within a study population of extremely obese patients: feasibility on a short, wide-bore MR scanner.
    Springer F; Machann J; Schwenzer NF; Ballweg V; Würslin C; Schneider JH; Fritsche A; Claussen CD; Schick F
    Invest Radiol; 2010 Aug; 45(8):484-90. PubMed ID: 20479651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is MR spectroscopy really the best MR-based method for the evaluation of fatty liver in diabetic patients in clinical practice?
    Parente DB; Rodrigues RS; Paiva FF; Oliveira Neto JA; Machado-Silva L; Lanzoni V; Campos CF; Eiras-Araujo AL; do Brasil PE; Garteiser P; Gomes MB; de Mello Perez R
    PLoS One; 2014; 9(11):e112574. PubMed ID: 25426708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities.
    Guaraldi G; Besutti G; Stentarelli C; Zona S; Nocetti L; Loria P; Ballestri S; Losi L; Torricelli P; Ligabue G
    Antivir Ther; 2012; 17(6):965-71. PubMed ID: 22766513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of dual-echo (in- and opposed-phase) T1-weighted gradient recalled echo for detection and grading of hepatic iron using quantitative and visual assessment.
    Schieda N; Ramanathan S; Ryan J; Khanna M; Virmani V; Avruch L
    Eur Radiol; 2014 Jul; 24(7):1437-45. PubMed ID: 24788037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?
    Satkunasingham J; Nik HH; Fischer S; Menezes R; Selzner N; Cattral M; Grant D; Jhaveri K
    Liver Transpl; 2018 Apr; 24(4):470-477. PubMed ID: 29080242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.